Inc. reported its fourth-quarter 2024 earnings, revealing an adjusted diluted EPS of $2.14, which fell short of the forecasted $2.36. Despite this miss, the company's stock price increased by 2.63% in ...
Fake papers are contaminating the world's scientific literature, fueling a corrupt industry and slowing legitimate lifesaving medical research, with an estimated 55,000 scholarly papers retracted to d ...